Meeting
2020 ASCO Virtual Scientific Program
The contribution of clinical subtype to survival differences among patients with de novo and recurrent metastatic breast cancer (dMBC).
Authors
Danielle Marie File
University of North Carolina, Chapel Hill, NC
Danielle Marie File , Tomas Pascual , Allison Mary Deal , Amy Wheless , Elizabeth Claire Dees , Lisa A. Carey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1030)
DOI
10.1200/JCO.2020.38.15_suppl.1030
Abstract #
1030
Poster Bd #
115
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Correlation of HER2 low status in I-SPY2 with molecular subtype, response, and survival.
First Author: Hope S. Rugo
First Author: Shaakir Hasan
Poster
2013 Breast Cancer Symposium
Breast cancer patients with diabetes mellitus: Defining the population and assessing outcomes.
First Author: Nina J. Karlin
Poster
2012 ASCO Annual Meeting
The influence of prognostic factors on metastatic breast cancer survival over time.
First Author: Margaret Quinn Rosenzweig